I agree and that was the point I was trying to make. To value the patents would be speculative. The value is there IMP once trials commence and the science is proven. Does not say at some point major pharma steps in and buys or partners with Venturis.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.